Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
US5853623A · kind A · utility
6Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 1996 |
| Grant date | Dec 29, 1998 |
| Priority date | — |
| Expiry date | May 10, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/868
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns novel mercaptoalkylpeptidyl compounds of formula (I) which are useful inhibitors of matrix metalloproteinase and/or TNF-mediated diseases including degenerative diseases and certain cancers. The invention also concerns methods of treating patients suffering from disorders or diseases which can be attributed to or are associated with matrix metalloproteinase or TNF activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.